Answers are grounded in this paper and cite their sources.
A novel series of benzothiazole derivatives were synthesized and assayed in vivo to investigate their hypoglycemic activity by streptozotocin-induced diebetic model in rat. These derivatives showed considerable biological efficacy when compared to glibenclamide, a potent and well known antidiabetic agent as a reference drug. All the compounds were effective, amongst them 3d showed more prominent activity at 100 mg/kg p.o. The experimental results are statistically significant at p<0.01 and p<0.05 level.
No takes yet. Share an insight, caveat, or question.
Mariappan et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: